With integrated capabilities and vast knowledge of nasal and pulmonary delivery, We can help accelerate molecules from first-in-human through to proof-of-concept and into full development for inhaled drug products.
Our 30 year track record in the development and manufacturing of inhaled drug products includes experience across drug delivery platforms, including dry powder inhalers (DPIs) and solutions/suspensions for inhalation.
Oncology Drug Development
Innovation in oncology treatments is leading to improved outcomes for patients. We support oncology drug development from candidate selection through to commercial manufacture and supply. We have successfully completed over 300 development projects for 91 different oncology drug candidates across 34 different indications.
Our extensive formulation expertise coupled with our agile and flexible approach to clinical manufacturing and commercial manufacturing makes us the ideal partner to provide an end-to-end solution for the development of oncology drug.